Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Avant Immunotherapeutics reports on TP-10 progress

Jan. 19, 2000

Pre- and postischemic treatment with FR-183998 cardioprotective in rat models

Jan. 18, 2000

Sangamo and Baxter to collaborate on novel vascular disease therapeutics

Jan. 18, 2000

Avant Immunotherapeutics updates progress with CETi-1

Jan. 18, 2000

Collateral Therapeutics boosts cardiovascular gene therapy portfolio with new patent

Jan. 17, 2000

Health Canada grants priority review to Vanlev

Jan. 14, 2000

Myriad Genetics and Roche to collaborate on cardiovascular drug discovery

Jan. 13, 2000

Almirall Prodesfarma presents new PDE5 inhibitor series

Jan. 12, 2000

Priority review granted to antihypertensive drug Vanlev

Jan. 11, 2000

Human Genome Sciences discloses novel growth-regulatory protein, its production and use

Jan. 11, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...